1. At a Glance – The Agro IPO That Got Smacked 36% in 6 Months
Indogulf Cropsciences Ltd is currently sitting at ₹69.6, down 36.4% in six months and 29.7% in three months. Market cap? A humble ₹440 crore. Price-to-book? A suspiciously clean 1.00x. P/E? Just 12.3x versus industry median of ~29x.
Latest Q3 FY26 numbers:
- Revenue: ₹108.58 crore (₹1,161 mn in press release context)
- PAT: ₹4.11 crore
- EPS: ₹0.65
- OPM: 10.5%
ROE stands at 12.2%, ROCE at 13.2%, debt at ₹204 crore, and interest coverage at 4.12x.
This is an agrochemical company with 90% revenue from crop protection, exporting to 34 countries, fresh from a ₹200 crore IPO, trading at book value… and investors are still not impressed.
Question is — is this a sleepy agro stock unfairly punished, or did the IPO sugar rush wear off too quickly?
Let’s open the pesticide bottle and read the label carefully.
2. Introduction – From Family Business to IPO Baby
Founded in 1993, Indogulf is one of those North Indian agrochemical players that quietly grew in the background while giants like UPL and P I Industries hogged headlines.
Then came July 3, 2025. IPO. ₹200 crore raised. Bell rings. Confetti falls. Retail investors clap.
Fast forward 6 months.
Stock falls 36%.
Welcome to the stock market, where celebration is temporary and quarterly margins are permanent.
But here’s the twist:
This isn’t some loss-making experiment. The company has been profitable consistently. FY25 PAT: ₹32 crore. TTM PAT: ₹36 crore.
And Q3 FY26 revenue rose 17% YoY per official press release (₹1,161 mn). That’s not exactly funeral music.
So why the cold shoulder?
Is it:
- Low growth?
- High working capital?
- Agro sector cyclicality?
- Or just smallcap allergy?
Let’s break it down piece by piece — like a
